Silco Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was BDT 109.97 million compared to BDT 124.23 million a year ago. Net income was BDT 17.11 million compared to BDT 21.68 million a year ago. Basic earnings per share from continuing operations was BDT 0.16 compared to BDT 0.21 a year ago.
For the nine months, sales was BDT 317 million compared to BDT 359.86 million a year ago. Net income was BDT 40.65 million compared to BDT 67.12 million a year ago. Basic earnings per share from continuing operations was BDT 0.39 compared to BDT 0.65 a year ago.